The Parkinson’s Disease Foundation (PDF) alerts the community that St. Jude Medical Infinity Deep Brain Stimulation (DBS) system has been approved by the US Food and Drug Administration (FDA) for the treatment of people living with Parkinson's. The manufacturer reports that its new system is designed to provide targeted control of Parkinson’s symptoms with fewer side effects. This new approval was announced by the manufacturer on October 6.
DBS is a therapy that involves surgically implanting electrical stimulators into the brain. Since its approval, it has become a standard surgical therapy for Parkinson’s disease. DBS is most effective for those who experience disabling tremors, wearing-off spells, slowness of movement and medication-induced dyskinesias.
The manufacturer of Infinity DBS reports that the system, by directing electrical current away from certain areas of the brain, may lead to fewer side effects. It also allows doctors and people with Parkinson’s to program their DBS system from certain mobile devices and offers a re-charge free battery, available in two sizes.
People with PD who have questions about whether they are candidates for DBS therapy are advised to consult a movement disorders specialist.